Cargando…

Describing settings of care in the last 100 days of life for cancer decedents: a population‐based descriptive study

BACKGROUND: Few studies have described the settings cancer decedents spend their end‐of‐life stage, with none considering homecare specifically. We describe the different settings of care experienced in the last 100 days of life by individuals with cancer and how settings of care change as they appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafid, Abe, Howard, Michelle, Webber, Colleen, Gayowsky, Ana, Scott, Mary, Jones, Aaron, Hsu, Amy T., Tanuseputro, Peter, Downar, James, Conen, Katrin, Manuel, Doug, Isenberg, Sarina R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972173/
https://www.ncbi.nlm.nih.gov/pubmed/36281530
http://dx.doi.org/10.1002/cam4.5291
_version_ 1784898267175190528
author Hafid, Abe
Howard, Michelle
Webber, Colleen
Gayowsky, Ana
Scott, Mary
Jones, Aaron
Hsu, Amy T.
Tanuseputro, Peter
Downar, James
Conen, Katrin
Manuel, Doug
Isenberg, Sarina R.
author_facet Hafid, Abe
Howard, Michelle
Webber, Colleen
Gayowsky, Ana
Scott, Mary
Jones, Aaron
Hsu, Amy T.
Tanuseputro, Peter
Downar, James
Conen, Katrin
Manuel, Doug
Isenberg, Sarina R.
author_sort Hafid, Abe
collection PubMed
description BACKGROUND: Few studies have described the settings cancer decedents spend their end‐of‐life stage, with none considering homecare specifically. We describe the different settings of care experienced in the last 100 days of life by individuals with cancer and how settings of care change as they approached death. METHODS: A retrospective cohort study from January 2013 to December 2017, of decedents whose primary cause of death was cancer, using linked population‐level health administrative datasets in Ontario, Canada. RESULTS: Decedents 125,755 were included in our cohort. The average age at death was 73, 46% were female, and 14% resided in rural regions. And 24% died of lung cancer, 7% breast, 7% colorectal, 7% pancreatic, 5% prostate, and 50% other cancers. In the last 100 days of life, decedents spent 25.9 days in institutions, 25.8 days receiving care in the community, and 48.3 days at home without any care. Individuals who died of lung and pancreatic cancers spent the most days at home without any care (52.1 and 52.6 days), while individuals who died of prostate and breast cancer spent the least days at home without any care (41.6 and 45.1 days). Regardless of cancer type, decedents spent fewer days at home and more days in institutions as they approached death, despite established patient preferences for an end‐of‐life experience at home. CONCLUSIONS: In the last 100 days of life, cancer decedents spent most of their time in either institutions or at home without any care. Improving homecare services during the end‐of‐life may provide people dying of cancer with a preferred dying experience.
format Online
Article
Text
id pubmed-9972173
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99721732023-03-01 Describing settings of care in the last 100 days of life for cancer decedents: a population‐based descriptive study Hafid, Abe Howard, Michelle Webber, Colleen Gayowsky, Ana Scott, Mary Jones, Aaron Hsu, Amy T. Tanuseputro, Peter Downar, James Conen, Katrin Manuel, Doug Isenberg, Sarina R. Cancer Med RESEARCH ARTICLES BACKGROUND: Few studies have described the settings cancer decedents spend their end‐of‐life stage, with none considering homecare specifically. We describe the different settings of care experienced in the last 100 days of life by individuals with cancer and how settings of care change as they approached death. METHODS: A retrospective cohort study from January 2013 to December 2017, of decedents whose primary cause of death was cancer, using linked population‐level health administrative datasets in Ontario, Canada. RESULTS: Decedents 125,755 were included in our cohort. The average age at death was 73, 46% were female, and 14% resided in rural regions. And 24% died of lung cancer, 7% breast, 7% colorectal, 7% pancreatic, 5% prostate, and 50% other cancers. In the last 100 days of life, decedents spent 25.9 days in institutions, 25.8 days receiving care in the community, and 48.3 days at home without any care. Individuals who died of lung and pancreatic cancers spent the most days at home without any care (52.1 and 52.6 days), while individuals who died of prostate and breast cancer spent the least days at home without any care (41.6 and 45.1 days). Regardless of cancer type, decedents spent fewer days at home and more days in institutions as they approached death, despite established patient preferences for an end‐of‐life experience at home. CONCLUSIONS: In the last 100 days of life, cancer decedents spent most of their time in either institutions or at home without any care. Improving homecare services during the end‐of‐life may provide people dying of cancer with a preferred dying experience. John Wiley and Sons Inc. 2022-10-24 /pmc/articles/PMC9972173/ /pubmed/36281530 http://dx.doi.org/10.1002/cam4.5291 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle RESEARCH ARTICLES
Hafid, Abe
Howard, Michelle
Webber, Colleen
Gayowsky, Ana
Scott, Mary
Jones, Aaron
Hsu, Amy T.
Tanuseputro, Peter
Downar, James
Conen, Katrin
Manuel, Doug
Isenberg, Sarina R.
Describing settings of care in the last 100 days of life for cancer decedents: a population‐based descriptive study
title Describing settings of care in the last 100 days of life for cancer decedents: a population‐based descriptive study
title_full Describing settings of care in the last 100 days of life for cancer decedents: a population‐based descriptive study
title_fullStr Describing settings of care in the last 100 days of life for cancer decedents: a population‐based descriptive study
title_full_unstemmed Describing settings of care in the last 100 days of life for cancer decedents: a population‐based descriptive study
title_short Describing settings of care in the last 100 days of life for cancer decedents: a population‐based descriptive study
title_sort describing settings of care in the last 100 days of life for cancer decedents: a population‐based descriptive study
topic RESEARCH ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972173/
https://www.ncbi.nlm.nih.gov/pubmed/36281530
http://dx.doi.org/10.1002/cam4.5291
work_keys_str_mv AT hafidabe describingsettingsofcareinthelast100daysoflifeforcancerdecedentsapopulationbaseddescriptivestudy
AT howardmichelle describingsettingsofcareinthelast100daysoflifeforcancerdecedentsapopulationbaseddescriptivestudy
AT webbercolleen describingsettingsofcareinthelast100daysoflifeforcancerdecedentsapopulationbaseddescriptivestudy
AT gayowskyana describingsettingsofcareinthelast100daysoflifeforcancerdecedentsapopulationbaseddescriptivestudy
AT scottmary describingsettingsofcareinthelast100daysoflifeforcancerdecedentsapopulationbaseddescriptivestudy
AT jonesaaron describingsettingsofcareinthelast100daysoflifeforcancerdecedentsapopulationbaseddescriptivestudy
AT hsuamyt describingsettingsofcareinthelast100daysoflifeforcancerdecedentsapopulationbaseddescriptivestudy
AT tanuseputropeter describingsettingsofcareinthelast100daysoflifeforcancerdecedentsapopulationbaseddescriptivestudy
AT downarjames describingsettingsofcareinthelast100daysoflifeforcancerdecedentsapopulationbaseddescriptivestudy
AT conenkatrin describingsettingsofcareinthelast100daysoflifeforcancerdecedentsapopulationbaseddescriptivestudy
AT manueldoug describingsettingsofcareinthelast100daysoflifeforcancerdecedentsapopulationbaseddescriptivestudy
AT isenbergsarinar describingsettingsofcareinthelast100daysoflifeforcancerdecedentsapopulationbaseddescriptivestudy